Invention Grant
- Patent Title: Heteroaryl compounds as kinase inhibitor
-
Application No.: US16979195Application Date: 2019-03-13
-
Publication No.: US11767296B2Publication Date: 2023-09-26
- Inventor: Yan Feng , Ruyong Wang , Junqing Li , Jianjia Zheng , Xin Lian , Xuan Gong , Yueli Fu , Xinshan Kang
- Applicant: FUJIAN HAIXI PHARMACEUTICALS CO., LTD
- Applicant Address: CN Fujian
- Assignee: FUJIAN HAIXI PHARMACEUTICALS CO., LTD
- Current Assignee: FUJIAN HAIXI PHARMACEUTICALS CO., LTD
- Current Assignee Address: CN Fujian
- Agency: Apex Attorneys at Law, LLP
- Agent Yue (Robert) Xu
- Priority: CN 1810212171.9 2018.03.15 CN 1810835038.9 2018.07.26
- International Application: PCT/CN2019/078006 2019.03.13
- International Announcement: WO2019/174601A 2019.09.19
- Date entered country: 2020-09-09
- Main IPC: C07D213/73
- IPC: C07D213/73 ; C07D213/22 ; C07D241/20 ; C07D401/04 ; C07D401/12 ; C07D401/14 ; C07D405/12 ; C07D405/14 ; C07D409/12 ; C07D409/14 ; C07D413/12 ; C07D417/12 ; C07D417/14

Abstract:
Provided herein are compounds of formula (I) having activity on a receptor protein tyrosine kinase, wherein R1, R2, R3, A, Q, Z, X and W are set forth in the description, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof.
Public/Granted literature
- US20220380312A1 HETEROARYL COMPOUNDS AS KINASE INHIBITOR Public/Granted day:2022-12-01
Information query
IPC分类: